CNAT

Conatus Pharmaceuticals News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Conatus Pharmaceuticals Inc CNAT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.556 20:00:00
Close Price Low Price High Price Open Price Previous Close
0.556
more quote information »

Recent News

Date Time Source Heading
6/05/202016:03EDGARCurrent Report Filing (8-k)
6/01/202008:02EDGARCurrent Report Filing (8-k)
5/29/202016:11EDGARStatement of Changes in Beneficial Ownership (4)
5/29/202016:10EDGARInitial Statement of Beneficial Ownership (3)
5/28/202019:56EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202019:56EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202019:55EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202019:54EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202019:52EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202019:51EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202019:51EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202019:50EDGARStatement of Changes in Beneficial Ownership (4)
5/28/202019:48EDGARInitial Statement of Beneficial Ownership (3)
5/28/202019:47EDGARInitial Statement of Beneficial Ownership (3)
5/28/202019:46EDGARInitial Statement of Beneficial Ownership (3)
5/28/202019:45EDGARInitial Statement of Beneficial Ownership (3)
5/28/202019:43EDGARInitial Statement of Beneficial Ownership (3)
5/28/202019:42EDGARInitial Statement of Beneficial Ownership (3)
5/28/202019:41EDGARInitial Statement of Beneficial Ownership (3)
5/28/202019:40EDGARInitial Statement of Beneficial Ownership (3)
5/28/202008:30EDGARCurrent Report Filing (8-k)
5/27/202008:42EDGARCurrent Report Filing (8-k)
5/27/202006:10EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202006:07EDGARStatement of Changes in Beneficial Ownership (4)
5/27/202006:06EDGARStatement of Changes in Beneficial Ownership (4)
5/21/202016:13EDGARCurrent Report Filing (8-k)
5/18/202016:11EDGARFiling of Certain Prospectuses and Communications in..
5/18/202008:00GLOBELeading Independent Proxy Advisory Firms Recommend Conatus..
5/14/202016:07EDGARFiling of Certain Prospectuses and Communications in..
5/14/202008:00GLOBEHistogen Publishes Preclinical Data on its HST 004 Spinal..
5/11/202016:08EDGARFiling of Certain Prospectuses and Communications in..
5/11/202008:16EDGARFiling of Certain Prospectuses and Communications in..
5/11/202008:00GLOBEHistogen Receives US FDA IND Approval to Initiate Phase..
5/07/202016:18EDGARCurrent Report Filing (8-k)
5/07/202016:16EDGARFiling of Certain Prospectuses and Communications in..
5/07/202016:05GLOBEThe Conatus Pharmaceuticals Special Meeting of Stockholders..
5/01/202016:32EDGARQuarterly Report (10-q)
5/01/202016:06EDGARFiling of Certain Prospectuses and Communications in..
5/01/202016:05EDGARCurrent Report Filing (8-k)
5/01/202016:05GLOBEConatus Pharmaceuticals Reports First Quarter 2020 Financial..
5/01/202008:32EDGARFiling of Certain Prospectuses and Communications in..
4/22/202016:16EDGARFiling of Certain Prospectuses and Communications in..
4/20/202008:16EDGARFiling of Certain Prospectuses and Communications in..
4/20/202008:00GLOBEHistogen Announces Investigational Device Exemption..
4/15/202008:16EDGARFiling of Certain Prospectuses and Communications in..
4/15/202008:00GLOBEHistogen Publishes New Preclinical Data on its HST 003..
4/06/202008:16EDGARFiling of Certain Prospectuses and Communications in..
4/06/202008:00GLOBEHistogen Announces Investigational New Drug Application..
4/02/202006:01EDGARNotice of Effectiveness (effect)
4/01/202016:48EDGARProspectus Filed Pursuant to Rule 424(b)(3) (424b3)
See more news about this stock »
Your Recent History
NASDAQ
CNAT
Conatus Ph..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200924 19:00:17